The Gluten-Casein-free Diet in Children With Autism: A Clinical Results of the Ophthalmic and Behavioral Manifestations
Effect of Gluten-free, Casein-free Diet in Children With Autism
1 other identifier
interventional
30
1 country
1
Brief Summary
To evaluate the efficacy of eight weeks of GFCF in children with ASD on autistic symptoms and ophthalmic findings such as corneal reflex, interpupillary distance (IPD) and pupil size.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 18, 2023
CompletedFirst Submitted
Initial submission to the registry
April 26, 2023
CompletedFirst Posted
Study publicly available on registry
May 8, 2023
CompletedMay 8, 2023
May 1, 2023
1.3 years
April 26, 2023
May 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Gilliam Autism Rating Scale 2 (GARS-2)
Based on DSM-IV autism diagnostic criteria, GARS-2 is a behavior checklist for children and teenagers aged 3 to 22. The three subscales of the scale are communication, social interaction, and stereotypical behavior. Each subscale contains 14 items that are scored on a four-point scale (0: Never observed, 1: Rarely observed, 2: Sometimes observed, 3: Often observed). The total score obtained from the scale is converted into standard scores, and an OBI score is obtained. An OBI score of 85 and above indicates a high probability of having ASD, a score between 70-84 indicates a medium probability, and a score of 69 and below indicates a low probability.
8 weeks
Weight (kg)
Body weight was measured in kilograms.
8 weeks
Body mass index
Body mass index (BMI)=weight/(height)\^2
8 weeks
Secondary Outcomes (1)
The pupil measurements
8 weeks
Study Arms (1)
Gluten Free Casein Free Diet
EXPERIMENTALFoods containing gluten (pasta, bread, etc.), casein (unfermented dairy products), and their disguised sources have been eliminated from the nutrition program. Also, packaged foods (chocolate, crackers, etc.) containing additives such as artificial preservatives, food coloring, and sweeteners that create a tendency to consume in children were avoided from the nutrition program. Goat milk contains type A2 casein, and most of the casein is digested in fermented dairy products. In order to increase calcium intake, the consumption of some foods (dill, kale, spinach, chard, arugula, broccoli, parsley, legumes, nuts, tahini, etc.) has been increased. Elimination was done gradually, considering nervousness, anxiety, etc., due to the effects of opioid mechanisms of action and gastrointestinal system symptoms.
Interventions
Thirty children with autism were evaluated before the diet (Pre-Test) and after 8 weeks of dietary intervention (Post-Test).
Eligibility Criteria
You may qualify if:
- Informed consent / Assent, as applicable must be signed prior to executing any study related procedure
- Children, male or female, 2 to 11 years old (inclusive)
- Confirmed diagnosis of ASD according to the DSM-IV Symptom Checklist
- Ability to maintain a gluten- and casein-free diet during the study
You may not qualify if:
- Cardiovascular, psychiatric, autoimmune, cancer, etc. children with secondary different disease
- Children with any drug use
- Children currently receiving treatment with any alternative medical methods (eg.hyperbaric).
- Children with a diagnosis of celiac disease
- Children who have received any dietary treatment before
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Üsküdar University
Istanbul, 34672, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
April 26, 2023
First Posted
May 8, 2023
Study Start
November 26, 2020
Primary Completion
March 14, 2022
Study Completion
January 18, 2023
Last Updated
May 8, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share